JPRN-UMIN000048143已完成未知
Comparison between nanoliposomal irinotecan plus 5-FU/ folinic acid and S-1 monotherapy in metastatic pancreatic cancer: A propensity score-matched retrospective cohort study. - Comparison between nanoliposomal irinotecan plus 5-FU/ folinic acid and S-1 monotherapy in metastatic pancreatic cancer: A propensity score-matched retrospective cohort study.
Japan Oncology Network in Hepatobiliary and Pancreas0 个研究点目标入组 500 人开始时间: 2022年6月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCCEsophageal CancerNCT06501664Rui-hua Xu, MD, PhD360
招募中
2 期
Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRCColorectal Neoplasms MalignantNCT06643793Affiliated Hospital of Nantong University30
招募中
3 期
Efficacy of DEBIRI in colorectal cancer liver metastasesCondition 1: Colorectal cancer liver metastases. Condition 2: Colorectal cancer liver metastases. Condition 3: Colorectal cancer liver metastases.Secondary malignant neoplasm of liver and intrahepatic bile ductMalignant neoplasm of colonMalignant neoplasm of rectumC78.7IRCT20240627062267N1Tehran University of Medical Sciences116
招募中
3 期
Analysis of Liposomal irinotecan's pharmacokinetics and side effectsPancreatic cancer Onyvyde Irinotecan UGT1A1C535836Pancreatic cancerJPRN-jRCT1041200085ANDO Yuichi15
终止
2 期
Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic OriginLocally Advanced Digestive System Neuroendocrine CarcinomaLocally Advanced Pancreatic Neuroendocrine CarcinomaMetastatic Digestive System Neuroendocrine CarcinomaMetastatic Pancreatic Neuroendocrine CarcinomaRefractory Digestive System Neuroendocrine CarcinomaRefractory Pancreatic Neuroendocrine CarcinomaUnresectable Digestive System Neuroendocrine CarcinomaUnresectable Pancreatic Neuroendocrine CarcinomaNCT03736720Roswell Park Cancer Institute11